HOME > About Us > Fundamental Policy

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.

Fundamental Policy

RIBOMIC Inc. operates its business based on the following fundamental policy.

  • As a corporation involving research and development of pharmaceutical drugs for human life and health, we conduct our research based upon cutting-edge science and technology with emphasis on high ethical standards.
  • To maximize the corporate value and contribute to the social responsibility, we make our efforts to strengthen and commit “The Structure of Corporate Governance” and maintain the compliance and appropriate way of corporate execution of business.
  • As a listed corporation, we observe the “The Standard of Corporate Action” provided by the Tokyo Stock Exchange, enhance the disclosure of corporate information, secure the transparency of corporate management, and ensure the accountability. Furthermore, we maintain and develop good relationship with the stakeholders such as shareholders, customers and social community.